Bio-Reference Laboratories (BRLI) Tops Q1 Views
Tweet Send to a FriendGet Alerts BRLI Hot Sheet
Price: $28.54 -0.24%
Revenue Growth %: +8.0%
Financial Fact:
GROSS PROFIT ON REVENUES: 80.68M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: +8.0%
Financial Fact:
GROSS PROFIT ON REVENUES: 80.68M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade BRLI Now!
Bio-Reference Laboratories (NASDAQ: BRLI) reported Q1 EPS of $0.28, $0.11 better than the analyst estimate of $0.17. Revenue for the quarter came in at $121.66 million versus the consensus estimate of $119.12 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Actuant Corp. (ATU) Tops Q3 EPS by 3c; Trims FY13 Outlook, Guides FY14
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
